Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Posts tagged "#januvia"

Let's hope Actos, Januvia history is not repeated

The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.

Let's hope Actos, Januvia history is not repeated

The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.

Lawsuits center on incretin diabetes drugs

On Aug. 15, 2013, there were 53 lawsuits pertaining to four diabetes drugs centralized at the U.S. District Court for the Southern District of California. As of July 15, 463 such lawsuits were pending before that very same court. Many were transferred there by the U.S. Judicial Panel on Multidistrict Litigation, which is the body that establishes multidistrict litigation courts to carry out pretrial management of multiple cases.

Lawsuits center on incretin diabetes drugs

On Aug. 15, 2013, there were 53 lawsuits pertaining to four diabetes drugs centralized at the U.S. District Court for the Southern District of California. As of July 15, 463 such lawsuits were pending before that very same court. Many were transferred there by the U.S. Judicial Panel on Multidistrict Litigation, which is the body that establishes multidistrict litigation courts to carry out pretrial management of multiple cases.

A 'gliptin' drug singled out for FDA scrutiny

Since February, the U.S Food and Drug Administration has been investigating a potential link between the use of the diabetes drug saxagliptin and heart failure. AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company have marketed saxagliptin as the brand-name drugs Onglyza and Kombiglyze XR.

A 'gliptin' drug singled out for FDA scrutiny

Since February, the U.S Food and Drug Administration has been investigating a potential link between the use of the diabetes drug saxagliptin and heart failure. AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company have marketed saxagliptin as the brand-name drugs Onglyza and Kombiglyze XR.

Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map